Kinarus appoints chief medical officer

, , , ,

Kinarus appoints chief medical officer

Thierry Fumeaux, M.D., is now chief medical officer of Kinarus, a privately held, development-stage biotechnology company located in Basel, Switzerland. In this new role, Dr. Fumeaux is expected to provide leadership and direction to the clinical strategy of the company. He reports to Dr. Alexander Bausch, CEO, and serves on the senior management team.

“I am excited to join Kinarus at this stage of its development! “ Dr. Fumeaux says. “It is a fantastic opportunity for me to use my clinical experience and to participate actively to the development of new therapeutic options that have a potential to significantly improve the patients’ outcome in various diseases including Covid-19.”

Thierry Fumeaux

Dr. Fumeaux is a specialist in internal and intensive care medicine, with a long clinical experience as head of the Intensive Care Unit and the Internal Medicine department of the hospital of Nyon. He was a member of the Swiss National Covid Scientific Task Force, as president of its Clinical Care Expert group. He is also past president of the Swiss Society of Intensive Care Medicine, from 2018 to 2020.

“Dr Fumeaux’s expertise in intensive care and treatment of Covid-19 will be critical in advancing Kinarus’s clinical programs,” Dr. Bausch says. “His proven leadership, as well as his extensive medical and research experience, will strengthen our clinical development efforts and support the progress of our product pipeline especially in Covid-19.”

Dr Fumeaux has a physician’s diploma from the University of Lausanne, and an M.D. from the University of Geneva, where he was also adjunct professor. He also holds an MBA from IMD and the University of Lausanne.